Molina Healthcare Faces Securities Class Action Lawsuit for Misleading Statements

Faruqi & Faruqi, a leading national securities law firm, is investigating potential claims against Molina Healthcare, Inc. (NYSE: MOH) for allegedly making false and/or misleading statements about the company's financial guidance and medical cost trends. The firm is reminding investors of the December 2, 2025 deadline to seek the role of lead plaintiff in a federal securities class action.

As detailed below, the complaint alleges that Molina and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose material, adverse facts concerning the company's medical cost trend assumptions. On July 7, 2025, before the market opened, Molina issued a press release announcing financial results for the second quarter of 2025 and slashing full year 2025 adjusted earnings per share guidance. The company attributed its results to a "challenging medical cost trend environment," including mere "utilization of behavioral health, pharmacy, and inpatient and outpatient services." The company alleged its guidance cut also reflected "new information gained in the quarterly closing process."

On this news, Molina's stock price fell $6.97, or 2.9%, to close at $232.61 per share on July 7, 2025, on unusually heavy trading volume. Then, on July 23, 2025, after the market closed, Molina issued another press release reporting its financial results for the second quarter ended June 30, 2025 and further slashing the company's full-year 2025 earnings guidance. The company attributed its results to a "challenging medical cost trend environment" and "new information gained in the quarterly closing process." On this news, Molina's stock price fell $32.03, or 16.84%, to close at $158.22 per share on July 24, 2025, on unusually heavy trading volume.

Key Takeaways:

  • Faruqi & Faruqi, a leading national securities law firm, is investigating potential claims against Molina Healthcare, Inc. (NYSE: MOH) for allegedly making false and/or misleading statements about the company's financial guidance and medical cost trends.
  • The firm is reminding investors of the December 2, 2025 deadline to seek the role of lead plaintiff in a federal securities class action.
  • The complaint alleges that Molina and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose material, adverse facts concerning the company's medical cost trend assumptions.
  • On July 7, 2025, Molina issued a press release announcing financial results for the second quarter of 2025 and slashing full year 2025 adjusted earnings per share guidance.
  • The company attributed its results to a "challenging medical cost trend environment" and "new information gained in the quarterly closing process."
  • On this news, Molina's stock price fell $6.97, or 2.9%, to close at $232.61 per share on July 7, 2025, on unusually heavy trading volume.
  • Then, on July 23, 2025, Molina issued another press release reporting its financial results for the second quarter ended June 30, 2025 and further slashing the company's full-year 2025 earnings guidance.
  • On this news, Molina's stock price fell $32.03, or 16.84%, to close at $158.22 per share on July 24, 2025, on unusually heavy trading volume.

Statistics:

  • Molina's stock price fell $6.97, or 2.9%, to close at $232.61 per share on July 7, 2025, on unusually heavy trading volume.
  • Molina's stock price fell $32.03, or 16.84%, to close at $158.22 per share on July 24, 2025, on unusually heavy trading volume.
  • The firm is reminding investors of the December 2, 2025 deadline to seek the role of lead plaintiff in a federal securities class action.
  • The complaint alleges that Molina and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose material, adverse facts concerning the company's medical cost trend assumptions.

Sources:

  • Newsfile Corp. (October 17, 2025) - "Faruqi & Faruqi, LLP Announces Investigation into Molina Healthcare, Inc. (NYSE: MOH)"
  • New York, New York (October 17, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Molina Healthcare, Inc. (NYSE: MOH) and reminds investors of the December 2, 2025 deadline to seek the role of lead plaintiff in a federal securities class action.